Metacresol

Metacresol

SCHEMBL9102481

Cc1cccc(O)c1.O=C(O)C(Br)c1ccccc1Cl

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.47
CXCL8 P10145 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
CTSA P10619 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TRPV1 Q8NER1 1/20 0.36
IGFBP3 P17936 1/20 0.36
PTGS2 P35354 1/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
CRHR1 P34998 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16161639 0.86 TSHR (0.50) CXCL8MEN1KMT2ACYP1A2CYP3A4
SCHEMBL15485528 0.84 KDM4E (0.43) CXCL8MEN1KMT2ACYP1A2CYP3A4
SCHEMBL15485148 0.83 KMT2A (0.43) CXCL8MEN1KMT2ACYP1A2CYP3A4
SCHEMBL5112227 0.82 MEN1 (0.46) CXCL8MEN1KMT2ACYP1A2CYP3A4
SCHEMBL365284 0.82 MEN1 (0.46) CXCL8MEN1KMT2ACYP1A2CYP3A4
SCHEMBL8128086 0.82 MEN1 (0.46) CXCL8MEN1KMT2ACYP1A2CYP3A4
Parachlorophenol SCHEMBL9107453 0.78 MAPK1 (0.42) CXCL8MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9102485 0.74 LMNA (0.49) MEN1KMT2AALDH1A1POLBSMN1; SMN2
SCHEMBL15485315 0.74 CES2 (0.36) CXCL8MEN1KMT2AALDH1A1CTSA
SCHEMBL4596673 0.74 KMT2A (0.42) CXCL8MEN1KMT2ACYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140057952-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS ALLERGAN, INC. (US) 2014-02-27 US disclosed
US-8618139-B2 Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators ALLERGAN, INC. (US) 2013-12-31 US disclosed
US-20120142739-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS ALLERGAN, INC. (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140057952-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS S1PR3, S1PR1, S1PR2 ACHE 4704/4885CXCL8 2644/4885MEN1 3212/4885
US-20120142739-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS S1PR3, S1PR1, S1PR2 ACHE 4704/4885CXCL8 2644/4885MEN1 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.